Sanofi and Alnylam enter into strategic restructuring of RNAi therapeutics rare disease alliance
Page (1) of 1 - 01/07/18||
(January 07, 2018)
| || Press Release|
Source: Sanofi (EURONEXT: SAN) (NYSE: SNY)
HTN - Health Technology Net
DMN Newswire Newsletter
Source:Copyright (c) GlobeNewswire, Inc.
All Rights Reserved
National Oral Health Report: A State Of Decay
Global Medical Device Market 2018 with Forecasts to 2023 - Driven by Healthcare Expenditure / Technological Development / Aging Population / Chronic Diseases
Orthodontic Supplies Market to Hit 8.9% CAGR to 2023, Led by Align Technology, Inc. (US), 3M Company (US), and Danaher Corporation (US)
New Orleans' GAINSWave Offers GAINSWave® in Louisiana
Hearing Aids Market Is Estimated To Generate Revenues Worth USD 4.5 Billion By 2024: Grand View Research, Inc.
MOLOGEN AG: Announcement of the new dates for the publication of the Annual Financial Statements 2017 and the 2018 Annual General Meeting
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline - June 19, 2018
Generic Injectables Market to Generate a Revenue of US$ 150 Bn by 2025, Says TMR
Anpac Bio Wins 2018 International 'BIG Innovation Award'
Health Tourism Market 2018 Global Industry Size, Emerging Trends, Share, Growth Factors, with growing at a CAGR of 15.4% Forecast by 2025
About The Health Technology - Contact Us - Advertise With Us - Privacy